These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38203445)
21. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin. He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities. Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898 [TBL] [Abstract][Full Text] [Related]
23. A new reduced chalcone-derivative affects the membrane permeability and electric potential of multidrug-resistant Enterococcusfaecalis. Tempone AG; Theodoro RDS; Romanelli MM; Santos Ferreira DA; Amaral M; Ribeiro de Assis L; Santa Cruz LM; Costa AR; Zanella RC; Christodoulides M; Regasini LO; Camargo CH Chem Biol Interact; 2022 Sep; 365():110086. PubMed ID: 35940279 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of Novel Chalcone-Based Phenothiazine Derivatives as Antioxidant and Anticancer Agents. Al Zahrani NA; El-Shishtawy RM; Elaasser MM; Asiri AM Molecules; 2020 Oct; 25(19):. PubMed ID: 33036301 [TBL] [Abstract][Full Text] [Related]
26. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents Su Q; Xu B; Tian Z; Gong Z Acta Pharm; 2022 Sep; 72(3):389-402. PubMed ID: 36651540 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates. Othman EM; Fayed EA; Husseiny EM; Abulkhair HS Bioorg Chem; 2022 Jun; 123():105762. PubMed ID: 35358822 [TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies. Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695 [TBL] [Abstract][Full Text] [Related]
29. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies. Durgapal SD; Soni R; Umar S; Suresh B; Soman SS Chem Biol Drug Des; 2018 Jul; 92(1):1279-1287. PubMed ID: 29575807 [TBL] [Abstract][Full Text] [Related]
30. Substitution at Phenyl Rings of Chalcone and Schiff Base Moieties Accounts for their Antiproliferative Activity. Salem MS; Hussein RA; El-Sayed WM Anticancer Agents Med Chem; 2019; 19(5):620-626. PubMed ID: 30799796 [TBL] [Abstract][Full Text] [Related]
31. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies. Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672 [TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685 [TBL] [Abstract][Full Text] [Related]
33. Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Horta B; Freitas-Silva J; Silva J; Dias F; Teixeira AL; Medeiros R; Cidade H; Pinto M; Cerqueira F Molecules; 2023 Feb; 28(5):. PubMed ID: 36903405 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity. Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents. Burmaoglu S; Gobek A; Aydin BO; Yurtoglu E; Aydin BN; Ozkat GY; Hepokur C; Ozek NS; Aysin F; Altundas R; Algul O Bioorg Chem; 2021 Jun; 111():104882. PubMed ID: 33839582 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors. Wang G; Peng Z; Li Y Chem Pharm Bull (Tokyo); 2019 Jul; 67(7):725-728. PubMed ID: 30982797 [TBL] [Abstract][Full Text] [Related]
37. Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study. Lai W; Chen J; Gao X; Jin X; Chen G; Ye L Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958533 [TBL] [Abstract][Full Text] [Related]
38. New dimer and trimer of chalcone derivatives from anti-inflammatory and antinociceptive extracts of Schinopsis brasiliensis roots. Moreira BO; Vilar VLS; de Almeida RNS; Morbeck LLB; Andrade BS; Barros RGM; Neves BM; de Carvalho AL; Cruz MP; Yatsuda R; David JM J Ethnopharmacol; 2022 May; 289():115089. PubMed ID: 35143935 [TBL] [Abstract][Full Text] [Related]
39. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines. Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; LicĂnio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665 [TBL] [Abstract][Full Text] [Related]
40. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity. Farghaly TA; Masaret GS; Muhammad ZA; Harras MF Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]